FDA Approves Cosentyx for Hidradenitis Suppurativa Treatment

by | Dec 6, 2023 | News

The FDA just approved Cosentyx (secukinumab) for Hidradenitis Suppuritiva (HS). Hidrandenitis Suppurativa is a painful, long-term skin condition that causes skin abscesses and scarring.  This is one of the newest drugs approved for the condition.  Cosentyx is used in many other conditions including ankylosing spondylitis, psoriasis, and psoriatic arthritis. 


Submit a Comment

Your email address will not be published. Required fields are marked *

Want the latest articles, videos, special offers, and more?

Subscribe to stay up-to-date on the latest news, research, tips & tricks that I provide for my autoimmune family! BONUS - FREE Autoimmune Survival Guide when you subscribe!

You have Successfully Subscribed!

Pin It on Pinterest

Share This